1. Polin R, Randis TM. Perinatal infections and chorioamnionitis. Fanaroff and Martin's neonatalperinatal medicine. 11th ed. Philadelphia, PA: Elsevier; 2020. P. 809-14.
2. Remington JS, Klein JO. Remington & Klein infection disease of the fetus & newborn infant. 8th ed.
Philadelphia, PA: Elsevier; 2015. P. 1058-75.
3. MacDonald MG, Seshia MM. Avery's neonatology:pathophysiology and management of the newborn.
7th ed. Philadelphia: Lippincott Williams & Wilkins;2015. P. 983.
4. Roy A, Chandhari J, Sankar D, Ghosh P, Chakraborty S. Role of enteric supplementation of probiotics on late-onset sepsis by Candida species in preterm low birth weight neonates: a randomized, double blind, placebo-controlled trial. N Am J Med Sci. 2014;6(1):50-7.
5. AlFalah K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Evid Based Child Health. 2014; 9(3):584-671
6. Benjamin DK, Stoll BJ, Gantz MG, Walsh MC, Sánchez PJ, Das A, et al. Neonatal candidiasis: epidemiology,risk factors, and clinical judgment. Pediatrics. 2010;126(4):e865-73.
7. Romeo MG, Romeo DG, Trovato L, Oliveri S,Palermo F, Cota F, et al. Role of probiotics in the presentation of the enteric colonization by candida in preterm newborn: incidence of late-onset sepsis
and neurological outcome. J Perinatol. 2011;31(1):63-9.
8. Steinbach WJ. Epidemiology of invasive fungal infections in neonates and children. Clin Microbiol
Infect. 2010; 16(9):1321-7.
9. Zaoutis T. Candidemia in children. Curr Med Res Opin. 2010; 26(7):1761-8.
10. Agarwal RR, Agarwal RL, Chen X, Lua JL, Ang JY.Epidemiology of invasive fungal infections at two
tertiary care neonatal intensive care units over a 12-year period (2000-2011). Global Pediatr Health.2017; 4:2333794X17696684.
11. Aliaga S, Clark RH, Laughon M, Walsh TJ, Hope WW,Benjamin Dk, et al. Changes in the incidence of candidiasis in neonatal intensive care units.Pediatrics. 2014; 133(2):236-42.
12. Manzoni P, Jacqz-Aigrain E, Rizzollo S, Franco C,Stronati M, Mostert M, et al. Antifungal prophylaxis in neonates. Early Hum Dev. 2011; 87:S59-60.
13. Oncel MY, Erdeve O, Dilmen U. Probiotics for necrotizing enterocolitis: not always a success story.
J Pediatr. 2014; 165(2):417.
14. Pammi M, Abrams SA. Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in
preterm infants. Cochrane Database Syst Rev. 2015;2:CD007137.
15. Vongbhavit K, Underwood MA. Prevention of necrotizing enterocolitis through manipulation of the intestinal microbiota of the premature infant. Clin Ther. 2016; 38(4):716-32.
16. Johnson-Henry KC, Abrahamsson TR, Wu RY, Sherman PM. Probiotics, prebiotics, and synbiotics for the prevention of necrotizing enterocolitis. Adv Nutr. 2016; 7(5):928-37.
17. Nandhini LP, Biswal N, Adhisivam B, Mandal J, Bhat BV, Mathai B. Synbiotics for decreasing incidence of
necrotizing enterocolitis among preterm neonates - a randomized controlled trial. J Matern Fetal Neonatal Med. 2016; 29(5):821-5.
18. van den Nieuwboer M, Claassen E, Morelli L, Guarner F, Brummer RJ. Probiotic and synbiotic safety in infants under two years of age. Benef Microbes. 2014; 5(1):45-60.